Cargando…

Pembrolizumab-Induced Thyroiditis Shows PD-L1Expressing Histiocytes and Infiltrating T Cells in Thyroid Tissue - A Case Report

CONTEXT: Immune-related adverse events frequently take place after initiation of immune checkpoint inhibitors (ICI) therapy. The thyroid gland is the endocrine organ most commonly affected by ICI therapy, the pathological mechanism is still poorly understood. CASE DESCRIPTION: A 60-year old Upper Au...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jabkowski, Jörg, Loidl, Almute, Auinger, Barbara, Kehrer, Helmut, Sepp, Norbert, Pichler, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250423/ https://www.ncbi.nlm.nih.gov/pubmed/34220792 http://dx.doi.org/10.3389/fimmu.2021.606056

Ejemplares similares

Histiocytic sarcoma localised in the thyroid—a case report
por: De Vos, Filip Y. F. L., et al.
Publicado: (2008)

A 61-Year-Old Woman with Chronic Iron-Deficiency Anemia Due to a Cameron Lesion and a Response to Oral Application of Combined Poloxamer 407 with Hyaluronic Acid and Chondroitin Sulfate Following Single Treatment with Pantoprazole: A Case Report
por: Iliev, Iliyan Emilov, et al.
Publicado: (2021)

T-Cell/Histiocyte-Rich Large B-Cell Lymphoma of the Thyroid
por: Ichikawa, Satoshi, et al.
Publicado: (2013)

Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis
por: Zhao, Yan, et al.
Publicado: (2023)

Bone marrow infiltration of histiocytic sarcoma
por: Mitani, Sachiko, et al.
Publicado: (2018)

Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases
por: Fröhlich, Eleonore, et al.
Publicado: (2017)

SAT-481 Pembrolizumab-Induced Thyroiditis with Negative Thyroid Peroxidase Antibody
por: Ragunanthan, Branavan, et al.
Publicado: (2020)

An adult with severe leukocyte adhesion deficiency type 1
por: Geroldinger-Simić, Marija, et al.
Publicado: (2021)

Tissue Infiltrating LTi—Like Group 3 Innate Lymphoid Cells and T Follicular Helper Cells in Graves' and Hashimoto's Thyroiditis
por: Mohr, Audrey, et al.
Publicado: (2020)

MYCBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients
por: Wang, Guilin, et al.
Publicado: (2022)

Effect of the m6ARNA gene on the prognosis of thyroid cancer, immune infiltration, and promising immunotherapy
por: Xia, Minqi, et al.
Publicado: (2022)

Pediatric liver failure with massive sinusoidal infiltration of histiocytes
por: Irie, Rie, et al.
Publicado: (2021)

Thyroid peroxidase (TPO) expressed in thyroid and breast tissues shows similar antigenic properties
por: Godlewska, Marlena, et al.
Publicado: (2017)

Effect of FOXP2 transcription factor on immune infiltration of thyroid cancer and its potential clinical value
por: Xu, Lianghui, et al.
Publicado: (2022)

B cells from anti-thyroid antibody positive, infertile women show hyper-reactivity to BCR stimulation
por: Serény-Litvai, Timea, et al.
Publicado: (2022)

Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
por: Mabbitt, Joseph, et al.
Publicado: (2023)

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
por: Mehnert, Janice M., et al.
Publicado: (2019)

Dramatic Response to First Line Single Agent Pembrolizumab in Anaplastic Thyroid Carcinoma
por: Spalart, Valérie, et al.
Publicado: (2019)

SAT-516 A Severe Case of Pembrolizumab-Induced Thyroiditis
por: Lane, Kyrstin, et al.
Publicado: (2020)

Sanguisorbae Radix Suppresses Colorectal Tumor Growth Through PD-1/PD-L1 Blockade and Synergistic Effect With Pembrolizumab in a Humanized PD-L1-Expressing Colorectal Cancer Mouse Model
por: Lee, Eun-Ji, et al.
Publicado: (2021)

Based on different immune responses under the glucose metabolizing type of papillary thyroid cancer and the response to anti-PD-1 therapy
por: Xie, Wenjun, et al.
Publicado: (2022)

Thyroid function and associated mood changes after COVID-19 vaccines in patients with Hashimoto thyroiditis
por: Ma, Yifei, et al.
Publicado: (2023)

Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab
por: de Filette, Jeroen, et al.
Publicado: (2016)

SAT-477 Melanoma Treated with Pembrolizumab Leading to Thyroiditis and Subsequent Hypothyroidism
por: Fishel, Heather
Publicado: (2020)

A Rare Case of T-Cell Histiocyte Rich Large B-Cell Lymphoma of the Thyroid in a Patient With Hashimotos
por: Zainal, Abir, et al.
Publicado: (2021)

Association of Hashimoto’s thyroiditis and anti-thyroid antibodies with oral lichen planus: A cross-sectional study
por: Zhang, Tianyu, et al.
Publicado: (2022)

Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto’s Thyroiditis
por: Cui, Likun, et al.
Publicado: (2022)

Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination
por: van der Woude, Lieke L, et al.
Publicado: (2022)

Cepharanthine Blocks Presentation of Thyroid and Islet Peptides in a Novel Humanized Autoimmune Diabetes and Thyroiditis Mouse Model
por: Li, Cheuk Wun, et al.
Publicado: (2021)

Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
por: Iyer, Priyanka C., et al.
Publicado: (2018)

Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma
por: Boudin, Laurys, et al.
Publicado: (2022)

Histiocytic endometritis
por: Wader, Jyotsna V., et al.
Publicado: (2013)

Histiocytic sarcoma
por: Machado, Eduardo Silva, et al.
Publicado: (2011)

The Emerging Role of Epigenetics in Autoimmune Thyroid Diseases
por: Wang, Bin, et al.
Publicado: (2017)

The Roles of Exosomes in Immunoregulation and Autoimmune Thyroid Diseases
por: Zou, Junli, et al.
Publicado: (2021)

Pembrolizumab combined with anlotinib improves therapeutic efficacy in pulmonary sarcomatoid carcinoma with TMB-H and PD-L1 expression: a case report and literature review
por: Wu, Shugui, et al.
Publicado: (2023)

Nodal histiocytic sarcoma with prominent eosinophilic infiltration: expression of eotaxin-2 on tumor cells
por: Ohe, Rintaro, et al.
Publicado: (2021)

Changes of IgG N-Glycosylation in Thyroid Autoimmunity: The Modulatory Effect of Methimazole in Graves’ Disease and the Association With the Severity of Inflammation in Hashimoto’s Thyroiditis
por: Trzos, Sara, et al.
Publicado: (2022)

Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States
por: Tian, Wentao, et al.
Publicado: (2023)

Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19
por: Haslbauer, Jasmin D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qrf527qjfnadhd85ga1g73io84